Genentech Q1 Profit, Revenue Top Consensus; Sees FY07 EPS Growth ... - Trading Markets
April 11, 2007 Washington Post | Genentech Q1 Profit, Revenue Top Consensus; Sees FY07 EPS Growth ... Trading Markets, CA - Rituxan used in the treatment for non-Hodgkin's lymphoma and rheumatoid arthritis, garnered revenues of $535 million, reflecting a growth of 12% over the ... Genentech Announces First Quarter 2007 Results Genentech Net Rises 68% on Sales of Cancer Drugs (Update1) |
Abbott Laboratories opens new $450 million Puerto Rico plant - Worcester Telegram
April 11, 2007| Abbott Laboratories opens new $450 million Puerto Rico plant Worcester Telegram, MA - Humira was first approved in 2002 as a treatment for rheumatoid arthritis. Since then, US regulators have approved Humira for psoriatic arthritis, ... Abbott Opens New Biotechnology Manufacturing Facility in Puerto Rico |
ReceptoPharm Patent for a Method of Treating Multiple Sclerosis - Therapeutics Daily (subscription) (press release)
April 11, 2007| ReceptoPharm Patent for a Method of Treating Multiple Sclerosis Therapeutics Daily (subscription) (press release), PA - ... including Multiple Sclerosis (MS) and Rheumatoid Arthritis. The patent discusses a method of treatment that uses ReceptoPharm's lead drug candidate, ... |
• Stem Cell Treatment May "Cure" Diabetes - Consumer Affairs
April 11, 2007 Earthtimes.org | • Stem Cell Treatment May "Cure" Diabetes Consumer Affairs - ... scleroderma, and rheumatoid arthritis. "The beauty of the treatment protocol used here is that the patient's own bone marrow stem cells were used, ... In Treatment of Diabetes Treatment gets Type 1 diabetics off insulin Diabetics cured by stem-cell treatment |
Treatment gets Type 1 diabetics off insulin - Allentown Morning Call
April 11, 2007 Portable Planet | Treatment gets Type 1 diabetics off insulin Allentown Morning Call, PA - The strategy is similar to an approach that has shown some success in treating other immune system disorders, such as rheumatoid arthritis, lupus and ... In Treatment of Diabetes Diabetics cured by stem-cell treatment Stem Cells Used In Diabetes Treatment |
Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP ... - PR Newswire (press release)
April 11, 2007| Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP ... PR Newswire (press release), NY - Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer. ... Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP ... |
Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP ... - PharmaLive.com (press release)
April 11, 2007| Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP ... PharmaLive.com (press release), PA - Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer. ... |
Stem cell treatment used for diabetes - Boston Globe
April 11, 2007 KOMO | Stem cell treatment used for diabetes Boston Globe, MA - The strategy is similar to an approach showing some success in treating other immune-system disorders, such as rheumatoid arthritis, lupus, and multiple ... Diabetics cured by stem-cell treatment Stem Cells Used In Diabetes Treatment Diabetes 'blocked by stem cells' |